1.Options of the diagnosis and treatment according to evidence-based patients with prostate carcinoma
Chinese Journal of Urology 2021;42(3):161-163
Prostate cancer (PC) is the most common malignancy in elderly men. While the majority of PC keeps an indolent biological behavior and progresses slowly, quite a few progresses very fast with poor prognosis. Urologists should take into account of patients′age, general health status and tumor pathology to make an appropriate strategy for PC clinical management. Prostate specific antigen (PSA), digital rectal examination (DRE), magnetic resonance imaging (MRI) of prostate and prostate biopsy are main tools for PC diagnosis. However, appropriate application of all kinds of diagnostic tests to prevent overdiagnosis and overtesting cannot be overemphasized, because methodological defects objectively exist. DRE is a basic examination which is able to provide valuable information for diagnosis. There are multiple therapeutic options for PC with generally similar efficacy and individual shortcoming, which stresses the importance of patients’ consents and choices. Managements of severe complications of advanced PC is critical for improving patients’ life quality.
2.Development of traditional Chinese medicine in Arab countries: present status and suggestions in the background of Belt and Road Initiative
International Journal of Traditional Chinese Medicine 2017;39(9):769-772
Arab countries have long tradition of using traditional medicine which enjoys mass foundation among local people. Recently, China's import and export trade of traditional medicine products with Arab countries showed an increasing trend year by year. With the implementation of the Belt and Road Strategy, Arab countries played a more important role in China's foreign trade. With the aim of promoting the spread of traditional Chinese medicine (TCM) in Arab countries, cooperation with relevant countries shall be differentiated. The Gulf region is economically advanced with its people enjoying prosperity, where is suitable for developing TCM product and service trade. The Levant has strong advantages in traditional medicine research, where academic communication shall be frequented. Countries in north Africa enjoy profound traditional friendship with China, where are suitable for dispatching Chinese foreign aid medical team to promote TCM. Meanwhile, we are supposed to take advantage of Confucius Institute and Chinese culture centers as platforms to spread TCM culture, to strengthen cooperation with medical universities and research institutions in the target countries, to enroll more Arab students to study TCM, to develop international standard Chinese-Arabic basic nomenclature of Chinese Medicine, and to carry out Traditional Arabic & Islamic Medicine researches.
3.Short-term clinical evaluation of photoselective vaporization of the prostate for the patients with benign hyperplasia of prostate in anti-coagulanting status
Jie SUN ; Dong LI ; Yiran HUANG
Chinese Journal of Urology 2013;(5):366-368
Objective To evaluate the safety and efficacy of the photoselective prostate vaporization (PVP) for the patients of benign hyperplasia of prostate (BPH) with oral anti-coagulant.Methods From September 2008 to May 2010,7 cases of BPH with oral anti-coagulant were treated by PVP,with an average age of 74 years.The prothrombin time before the surgery was (13.14 ± 0.15) s.An 100 W Green-light laser source was applied in this study.The prostate volume,operating time,blood loss,catheter indwelling time after the surgery,hospital stay,PVR,Q IPSS score were recorded.Results The mean operating time was (65 ± 22) min without active bleeding or transfusion in this cohort.The haemoglobulin concentration was intact and catheter indwelling time was (22 ± 8) h,while the hospital stay was (2.7 ± 1.2) d.The PVR,Q IPSS score were significantly improved after follow-up of 1 month (P <0.01).One case complicated acute urinary retention after operation in this cohort,and the catheter was removed 4 weeks after α-blocker administration.Conclusions PVP is a safe and effective surgical strategy for BPH patients with oral anti-coagulant.However,since there were relatively limited cases enrolled in this study,more randomized controlled clinical trials are needed in the near future.
4.Renal pathological features in von Hippel-Lindau disease
Jin ZHANG ; Yiran HUANG ; Lianfang DU
Chinese Journal of Urology 2001;0(11):-
Objective To investigate the features of renal lesions in von Hippel-Lindau (VHL) disease and the surgical intervention. Methods The clinical and pathological data from 6 patients with renal lesions in a large Chinese VHL disease kindred were reviewed individually.One patient had multifocal renal cysts,and 5 patients had bilateral renal cell carcinomas and multifocal renal cysts. Results Among 10 kidneys in the 5 cases of bilateral renal cell carcinomas, nephron-sparing surgery (NSS) was performed in 5,radical nephrectomy (RN) in 3 and observation in 2.After operation,the pathological findings indicated that all solid lesions were renal clear cell carcinoma, with one malignant cyst being detected.The Fuhrman's nuclear grade of the RCC was grade Ⅰ in 14 tumors,grade Ⅱ in 6 tumors.The TNM stage was T 1N 0M 0 in 4 cases and T 2N 0M 0 in 1 case.During a mean follow-up of 47 months (range,9 to 113 months),all patients were alive without evidence of RCC recurrence and metastasis.Five patients had normal renal function and 1 patient experienced an increase in serum creatinine but without dialysis. Conclusions The renal lesions in VHL disease include both cysts and carcinomas,which are often multifocal and bilateral.Almost all the tumors are of clear cell type with a low stage and grade.Nephron-sparing surgery may be justified and effective in the management of VHL patients.
5.Phase Ⅳ clinical trial of sorafenib in combination with interferon-alpha as the first-line treatment in patients with advanced renal cell carcinoma:interim analysis of efficacy and safety
Yiran HUANG ; Jianhui MA ; Jian HUANG ; Yanqun NA ; Yan SUN
Chinese Journal of Urology 2010;31(1):5-7
Objective To evaluate the efficacy and safety of sorafenib in combination with interferon-alpha(IFN-α)as the first-line treatment in patients with advanced renal cell carcinoma.Methods Since Dec 2007 to Jun 2008,137 legal patients with advanced renal cell carcinoma (RCC)were enrolled in the trail from 22 hospitals in China.All the patients continuously received the treatment of sorafenib plus IFN-α untill disease progressed or patients were unable to tolerate.The primary end points were objective response,disease control rate and adverse effects rate.Results This interim analysis was based on the data collected from the study initiation date to 2009/3/20.The overall response rate(ORR),including complete response (CR) and partial response(PR),was 32.8%(45/137).The median follow-up time was 11.9 months,only 25 patients progressed at the cut off time.The most common adverse events were hand-foot skin reaction(48.2%),alopecia(23.4%),rash (20.4%),diarrhea(19.7 0A),fever(16.8%),lassitude(10.2%),etc.The incidence of 3 or 4 grade hand-foot skin reaction was 8.8%.Conclusions Sorafenib in combination with IFN-α as the firstline treatment in patient with advanced RCC could be effective and safe.
6.Clinical study of combination therapy of tamsulosin and solifenacin for benign prostatic hyperplasia with overactive bladder
Chen JIANG ; Kai SUN ; Yonghui CHENG ; Wei XUE ; Yiran HUANG
Chinese Journal of Urology 2011;32(9):639-642
ObjectiveTo evaluate the efficacy and safety of combination therapy of tamsulosin and solifenacin for benign prostatic hyperplasia ( BPH ) with overactive bladder ( OAB ).Methods82 patients with OAB and coexisting BPH were randomly divided into tamsulosin group ( n = 38 ) and combination group ( n = 44). The ages were from 50 to 75 y ( averaged, 56.8 ± 8.6). Inclusion criteria: the mean frequency of micturition ≥8 times per day, the frequency of nocturia ≥2 times per day, voiding volume <200 ml each time; for the overactive bladder symptom score ( OA BSS), the 3 rd score > 2, total score > 3. The tamsulosin group accepted tamsulosin 0.2 mg once daily, the combination group accepted tansulouxin 0.2 mg and solifenacin 0.2 mg once daily. Both groups were maintained the corresponding therapy for 12 weeks.The international prostate symptom score (IPSS), Qmax, residual urine volume, OAB score and adverse reactions were recorded.ResultsThe values of IPSS ( 19.5 ±2.2 vs 15.6 ±2.4, P =0.027), the voiding symptom score ( 15.6 ± 2.4 vs 3.4 ± 1. 7, P = 0. 022) and Qmax ( 13.7 ± 3.8 vs 16.6 ± 4.1, P = 0. 034 )improved significantly after treatment in tamsulosin group ( P < 0. 05 ). The values of IPSS ( 19.7 ± 2.3 vs 9.7 ± 3.0, P <0. 001), the storage symptom score (13.8 ± 1.9 vs 5.6 ± 1.6, P <0. 001 ), OABSS (10.3 ±1.8 vs 5.3 ±1.3, P <0.001) and Qmax(14.1 ±4.1 vs 17.2 ±3.5, P=0.027) also improved significantly after treatment in combination group ( P < 0. 05 ). The values of IPSS ( 9.7 ± 3.0 vs 15.6 ±2.4, P < 0.001 ), the storage symptom score (5.6 ± 1.6 vs 12.0 ± 1.6, P < 0.001 ) and OABSS ( 5.3 ±1.3 vs 9.7 ± 2.7, P < 0. 001 ) improved significantly in combination group than those in tamsulosin group ( P <0.001 ). There were no difference between two groups in values of the voiding symptom score, Qmax and residual urine volume ( P > 0.05 ). The incidences of adverse reactions in tamsulosin group and combination group were 7.9% (3/38) and 20.5% (9/44) without significant difference. There was no acute urinary retention in both groups.ConclusionsIt is effective and safe for patients with BPH and OAB to accept combination therapy of tamsulosin and solifenacin.
7.Expression of Oct4 protein in non-muscle-invasive bladder cancer
Haifeng JIANG ; Lianhua ZHANG ; Juanfie BO ; Dongming LIU ; Yiran HUANG
Journal of International Oncology 2011;38(11):876-878
Objective To investigate the expression of Oct4 protein and analyze its correlation with the clinic pathological features and prognosis of non-muscle-invasive bladder cancer.Methods The oct4 protein expression was assessed by immunohistochemical analysis in 87 specimens of bladder transitional cell carcinoma and 15 specimens of adjacent normal tissues.A correlation between Oct4 and clinic pathological features was analyzed.Results The positive rate of Oct4 protein was significantly higher in bladder cancer than that in normal bladder tissue (P<0.01).The positive rate of Oct4 protein was 40.7% in G1 bladder cancer,69.4% in G2 bladder cancer and 91.7% in G3 bladder cancer,and the differences was significant (P<0.01).All patients were followed up for 3-78 months,and 63 of them relapsed.The expression of Oct4 protein was significantly higher in patients of recurrence than in non-recurrence (77.8% ∶ 37.5%,P < 0.01 ).21 patients of recurrence were in progression,and the expression of Oct4 protein had no significant differences between patients of progression and non-progression (71.4% ∶65.2%,P >0.05).The positive rate of Oct4 protein was not related with gender,age,tumor number and size (P >0.05).Conclusion The detection of Oct4 protein is in favor of early detection of bladder tunor,estimation the degree of differentiation and surveillance for recurrence of superficial bladder cancer.
8.Architecture and Functions of VR Vehicle for Rehabilitation
Jingyuan HUANG ; Haiyan LI ; Di LING ; Yiran XU ; Hongzeng LIU
Chinese Journal of Rehabilitation Theory and Practice 1998;4(4):163-166
In this paper we will discuss the architecture and functions of the VR vehicle for rehabilitation. There is no such report about this kind of VR vehicle for rehabilitation in open literature. Patients can select exercise modes for rehabilitation according to their individual health conditions. Patients can get rehabilitation faster and less painfully with the aid of this VR vehicle with which psychological treatment can be better introduced during the rehabilitation.
9.Renal vein trauma in the echo-guide percutaneous nephrostomy(3 cases report)
Wei XUE ; Jiahua PAN ; Haige CHEN ; Yiran HUANG
Chinese Journal of Urology 2008;29(12):829-832
Objective To discuss the management of renal vein trauma in the percutaneous ne-phrostomy (PCN) procedure.Methods Three cases with renal vein trauma by PCN or malposition of nephrostomic catheter were reviewed.Case 1 was a patient with staghorn calculi.There was mas-sive hemorrhage after the puncture and the dilatation during PCN.Then the nephrostomy catheter was clamped.The post-operative CT scan showed the nephrostomy catheter passed the inferior vena cava to the right external jugular vein.Case 2 was a patient with a 3 cm calculus in the inferior calice of the right kidney.A massive haemorrage occurred after the dilatation by the 16 F sheath guided by ultra-sound during PCN.The nephrostomic catheter was found in the renal vein by X-ray film.Case 3 was a patient with bilateral hydronephrosis complicating chronic renal failure,which caused by the meta-static of the gastric carcinoma.After the puncture,the massive hemorrage appeared and a nephros-tomic catheter was placed and then clamped.The catheter was seen in the renal vein confirmed by the X-ray.For all 3 patients,the catheter was withdrawn carefully monitored by the X-ray until the place of the renal vein perforation during the first 24-48h.Then it was withdrawn 3 to 4 cm each time un-til reach the pelvic.Results The hemorrhage was well controlled and nobody needed the surgical in-tervention.There was no renal function aggravation in these 3 patients.Conclusions The renal vein trauma during the echo-guide PCN procedure can be treated by clamping the nephrostomy catheter and withdrawing it gradually.Thus,the surgical intervention can be avoided and this method will not im-pair the renal function.
10.Expression of N-cadherin protein in urothelial bladder cancer and its relation to prognosis
Lianhua ZHANG ; Guoliang YANG ; Juanjie BO ; Dongming LIU ; Yiran HUANG
Chinese Journal of Urology 2014;35(5):337-340
Objective To explore the expression and significance of N-cadherin in urothelial bladder cancer and analyse its relation to clinicpathologic and prognosis of bladder cancer.Methods The expression of N-cadherin in 145 urothelial bladder cancer and 25 normal bladder tissues was detected by immunuhistochemisty,and correlations between N-cadherin and clinicopathologic features were analysed.Results The positive rate of N-cadherin protein was significantly higher in bladder cancer than in normal bladder tissue (P<0.01).The positive rate of N-cadherin protein was 38.6% in G1 bladder cancer,58.4% in G2-G3 bladder cancer,and its difference was significant (P =0.028).The expression was significantly lower in non-muscle-invasive bladder cancer than in muscle invasive bladder cancer (45.7% vs 64.7%,P=0.029).The muscle-invasive bladder cancer patients were followed up 4-103 months.Among those,the overall survival with positive expression of N-cadherin protein was 24.2% (8/33),and the overall survival with negative expression of N-cadherin protein was 66.7 % (12/18).Kaplan-Meier analysis showed the positive expression of N-cadherin was significantly associated with overall survival of patients with muscle-invasive-bladder cancer (P=0.002 2).Multivariate Cox analysis showed that N-cadherin expression was an important prognostic factor.Conclusions The expression of N-cadherin protein was high in bladder cancer.The detection of the expression of N-cadherin protein is associated with the diagnosis and prognosis of bladder cancer.